eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | neutropenia |
| Comorbidity | C0023530|leucopenia |
| Sentences | 7 |
| PubMedID- 25867940 | Hematologic abnormalities included moderate nonregenerative anemia, leucopenia with neutropenia, and moderate thrombocytopenia. |
| PubMedID- 23123176 | Blood work was available from 10 horses with clinical disease and common hematological abnormalities were leucopenia due to neutropenia and/or lymphopenia. |
| PubMedID- 22735906 | The major treatment-related adverse events are listed in table 2. the main toxicities were leucopenia (81% of patients), neutropenia (71.4%), decreased red blood cell counts (66.7%), decreased haematocrit (66.7%), nausea (66.7%), decreased appetite (61.9%), lymphocytopenia (61.9%), and decreased haemoglobin levels (57.1%). |
| PubMedID- 24238033 | Though leucopenia with or without neutropenia are characteristic hematological findings; its association with pancytopenia has been reported infrequently in english literature [25]. |
| PubMedID- 21647348 | The present study also revealed leucopenia apparently due to lymphopenia, neutropenia, and monocytopenia in the cpf group. |
| PubMedID- 25874134 | Laboratory findings showed severe leucopenia with neutropenia and thrombocytopenia. |
| PubMedID- 25496303 | In both treatment groups, there were mild decreases in mean white blood cell, neutrophil, eosinophil and monocyte counts to day 28, which remained stable until day 84. while the mean counts remained within the normal reference range, individual animals in both treatment groups developed a leucopenia, primarily due to neutropenia, during the study. |
Page: 1